1376766-58-3

Basic information

• Product Name: C₁₅H₁₄ClN₃O₄
• Synonyms: C₁₅H₁₄ClN₃O₄
• CAS NO: 1376766-58-3
• Molecular Weight: 335.747
• Mol File: 1376766-58-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: C₁₅H₁₄ClN₃O₄(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₅H₁₄ClN₃O₄(1376766-58-3)
• EPA Substance Registry System: C₁₅H₁₄ClN₃O₄(1376766-58-3)

Safety Data

• Hazardous Substances Data: 1376766-58-3(Hazardous Substances Data)

Upstream product

• 1147294-71-0 6-methyl-4-(3-nitrophenyl)-2-oxo-1,2-dihydropyrimidine-5-carboxylic acid isopropyl ester 
• 131275-78-0 Isopropyl 6-methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate 
• 542-08-5 isopropyl acetoacetate 
• 99-61-6 3-nitro-benzaldehyde 

Downstream Products

• 1376766-52-7 5-isopropyloxycarbonyl-6-methyl-4-(3-nitrophenyl)-2-[3-(7-chloroquinolin-4-ylamino)propylamino]pyrimidine 

Relevant articles and documents

Structure elaboration of isoniazid: synthesis, in silico molecular docking and antimycobacterial activity of isoniazid–pyrimidine conjugates

Abstract: Designing small molecule-based new drug candidates through structure modulation of the existing drugs has drawn considerable attention in view of inevitable emergence of resistance. A new series of isoniazid–pyrimidine conjugates were synthesize

2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies

2-Aminopyrimidine based 4-aminoquinolines were synthesized using an efficacious protocol. Some of the compounds showed in vitro anti-plasmodial activity against drug-sensitive CQS (3D7) and drug-resistant CQ R (K1) strains of Plasmodium falciparum in the nM range. In particular, 5-isopropyloxycarbonyl-6-methyl-4-(2-nitrophenyl)-2-[(7- chloroquinolin-4-ylamino)butylamino] pyrimidine depicted the lowest IC 50 (3.6 nM) value (56-fold less than CQ) against CQR strain. Structure-activity profile and binding with heme, μ-oxo-heme have been studied. Binding assays with DNA revealed better binding with target parasite type AT rich pUC18 DNA. Most compounds were somewhat cytotoxic, but especially cytostatic. Molecular docking analysis with Pf DHFR allowed identification of stabilizing interactions.